The American Thoracic Society has published its first official guidelines for how best to detect and diagnosis sarcoidosis in clinical…
Articles by Marisa Wexler, MS
Results of a Phase 1b/2a clinical study evaluating ATYR1923 in people with pulmonary sarcoidosis are likely to be delayed…
Boehringer Ingelheim‘s Ofev (nintedanib) has been approved in the U.S. as the first treatment for chronic fibrosing interstitial…
aTyr Pharma announced a collaboration and license agreement with Kyorin Pharmaceutical to develop and commercialize ATYR1923, its potential…
Acthar Gel (repository corticotropin injection, or RCI) can improve sarcoidosis symptoms, a real-world study shows. Titled “…
The University of California, Los Angeles (UCLA) is launching a fundraising initiative to help improve treatment for advanced lung…
Tears in blood vessels of the heart can occur in people with cardiac sarcoidosis, a case report found, although the…
An educational conference for people with sarcoidosis and those close to them will be held at the University…
According to a new study comparing older and younger sarcoidosis patients, elderly people with sarcoidosis tend to have more severe…
Work-related hazards account for nearly 1 in 3 cases of sarcoidosis, and for at least 1 in 10 cases of…